Clinical, Histological, and Immunohistochemical Findings in Inclusion Body Myositis

Clinical, Histological, and Immunohistochemical Findings in Inclusion Body Myositis

Sporadic inclusion body myositis (sIBM) is considered the most common acquired myopathy aged over 50 years. The disease is characterized by a particular process of muscle degeneration characterized by abnormal deposit of protein aggregates in association with inflammation. The aim of this study was...

Full description

Bibliographic Details
Main Authors:	Leonardo Valente de Camargo, Mary Souza de Carvalho, Samuel Katsuyuki Shinjo, Acary Souza Bulle de Oliveira, Edmar Zanoteli
Format:	Article
Language:	English
Published:	Hindawi Limited 2018-01-01
Series:	BioMed Research International
Online Access:	http://dx.doi.org/10.1155/2018/5069042

Similar Items

Sporadic inclusion body myositis in the rheumatology clinic
by: Fernando Henrique Carlos de Souza, et al.
Published: (2020-01-01)

Inclusion-body myositis: a difficult diagnosis?
by: Carolina da Cunha Correia, et al.
Published: (2014-10-01)

Inclusion Body Myositis Treated with Alemtuzumab
by: Juliana Sá, et al.
Published: (2019-12-01)

Sporadic inclusion body myositis: a rare hazardous entity with important imaging findings
by: Ana Catarina Vieira, et al.
Published: (2020-04-01)

Inclusion-Body Myositis Associated with Alzheimer’s Disease
by: Danijela Levacic, et al.
Published: (2013-01-01)

Mitochondrial Biology in Sporadic Inclusion Body Myositis
by: Shabrokh, Elika
Published: (2014)

Sporadic Inclusion Body Myositis: An Acquired Mitochondrial Disease with Extras
by: Boel De Paepe
Published: (2019-01-01)

Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositis
by: Marcela Gran Pina Cruellas, et al.
Published: (2013-07-01)

Sarcoidosis: Is It a Possible Trigger of Inclusion Body Myositis?
by: Ali Zakaria, et al.
Published: (2017-01-01)

Emerging therapeutic options for sporadic inclusion body myositis
by: Alfano LN, et al.
Published: (2015-09-01)

Inclusion body myositis – pathomechanism and lessons from genetics
by: Murnyák Balázs, et al.
Published: (2015-02-01)

Difficulties in the Diagnosis of Inclusion Body Myositis-Case Report
by: Bazic Danijela, et al.
Published: (2019-06-01)

The role of emerin in the pathogenesis of sporadic inclusion body myositis
by: Marini Bettolo, Chiara
Published: (2015)

Development and validation of a Bayesian survival model for inclusion body myositis
by: Gorana Capkun, et al.
Published: (2019-11-01)

Anesthetic management of a hydrocephalus patient with inclusion body myositis
by: Daiki Takekawa, et al.
Published: (2017-10-01)

Balloon Dilation in Sporadic Inclusion Body Myositis Patients with Dysphagia
by: Ken-ya Murata, et al.
Published: (2013-01-01)

Balloon Dilation in Sporadic Inclusion Body Myositis Patients with Dysphagia
by: Ken-ya Murata, et al.
Published: (2013-01-01)

A Rare Case of Sporadic Inclusion Body Myositis (s-IBM)
by: Sourya Acharya, et al.
Published: (2016-01-01)

Multicenter questionnaire survey for sporadic inclusion body myositis in Japan
by: Naoki Suzuki, et al.
Published: (2016-11-01)

Dysphagia in Patients with Sporadic Inclusion Body Myositis: Management Challenges
by: Mohannak N, et al.
Published: (2019-12-01)

Development of new therapeutic strategies for sporadic Inclusion Body Myositis
by: Miller, A. D.
Published: (2015)

Inclusion body myositis — a case based clinicopathological update
by: Bodoki Levente, et al.
Published: (2014-02-01)

Subcutaneous Immunoglobulin Use in Inclusion Body Myositis: A Review of 6 Cases
by: Patrick Cherin, et al.
Published: (2015-11-01)

Correlation between PET/CT results and histological and immunohistochemical findings in breast carcinomas
by: Almir Galvão Vieira Bitencourt, et al.
Published: (2014-04-01)

Mechanical Ventilation Weaning in Inclusion Body Myositis: Feasibility of Isokinetic Inspiratory Muscle Training as an Adjunct Therapy
by: Leonardo Cordeiro de Souza, et al.
Published: (2014-01-01)

The updated retrospective questionnaire study of sporadic inclusion body myositis in Japan
by: Naoki Suzuki, et al.
Published: (2019-06-01)

Pembrolizumab on pre-existing inclusion body myositis: a case report
by: Naohiro Uchio, et al.
Published: (2020-09-01)

Th1 response and systemic treg deficiency in inclusion body myositis.
by: Yves Allenbach, et al.
Published: (2014-01-01)

Impact of a Ketogenic Diet on Sporadic Inclusion Body Myositis: A Case Study
by: Matthew C. L. Phillips, et al.
Published: (2020-11-01)

Anti-NT5c1A Autoantibodies as Biomarkers in Inclusion Body Myositis
by: Adam Amlani, et al.
Published: (2019-04-01)

Metabolomes of mitochondrial diseases and inclusion body myositis patients: treatment targets and biomarkers
by: Jana Buzkova, et al.
Published: (2018-12-01)

Anesthetic Management for Inclusion Body Myositis in Coronary Artery Bypass Graft Surgery
by: Uoo Kim
Published: (2020-01-01)

Asymptomatic hyper-creatine-kinase-emia as sole manifestation of inclusion body myositis
by: Josef Finsterer, et al.
Published: (2013-06-01)

Autoantibodies against a 43 KDa muscle protein in inclusion body myositis.
by: Mohammad Salajegheh, et al.
Published: (2011-01-01)

Diagnostic Value of Muscle [11C] PIB-PET in Inclusion Body Myositis
by: Yu-ichi Noto, et al.
Published: (2020-01-01)

Investigating novel therapeutic approaches for sporadic inclusion body myositis (sIBM)
by: Ahmed, M.
Published: (2012)

Intramuscular dissociation of echogenicity in the triceps surae characterizes sporadic inclusion body myositis
by: Nodera, Hiroyuki
Published: (2016)

A Leydig Cell Tumour in a Cat: Histological and Immunohistochemical Findings
by: Pietro Asproni, et al.
Published: (2013-01-01)

HLA-DRB1 allele and autoantibody profiles in Japanese patients with inclusion body myositis.
by: Munenori Oyama, et al.
Published: (2020-01-01)

Investigating the effects of pharmacological upregulation of the heat shock response in models of inclusion body myositis
by: Spicer, Charlotte Jayne
Published: (2018)